Related Experiment Video

Updated: Aug 24, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Secondary hyperparathyroidism in chronic kidney disease: clinical consequences and challenges

Maureen Michael1, Donna Garcia

  • 1Central Florida Kidney Centers, Inc., Orlando, FL, USA.

Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association
|April 30, 2004
PubMed

Insights

Secondary hyperparathyroidism in chronic kidney disease (CKD) impacts multiple systems beyond bone. Current treatments often fail, highlighting the need for novel therapies to manage this complex condition and reduce patient mortality.

Area of Science:

  • Nephrology
  • Endocrinology
  • Mineral Metabolism

Background:

  • Secondary hyperparathyroidism (HPT) is a hallmark of chronic kidney disease (CKD).
  • It disrupts bone and mineral metabolism, leading to bone disease.
  • Beyond bone, HPT adversely affects cardiovascular, nervous, endocrine, and erythropoietic systems.

Purpose of the Study:

  • To review the multifaceted consequences of secondary hyperparathyroidism in CKD.
  • To evaluate the efficacy and limitations of current management strategies.
  • To underscore the need for improved therapeutic approaches.

Main Methods:

  • Literature review of secondary hyperparparathyroidism in CKD.
  • Analysis of the impact on mineral and bone disorder.
  • Assessment of current treatment outcomes and risks.

Main Results:

  • Secondary HPT in CKD causes systemic complications, not just bone disease.
  • Existing treatments struggle to control parathyroid hormone, calcium, and phosphate levels.
  • Current therapies may worsen mortality and morbidity in dialysis patients.

Conclusions:

  • Effective management requires balancing parathyroid hormone, calcium, and phosphate levels with vitamin D therapy.
  • Current therapeutic strategies are often inadequate and carry risks.
  • New treatments are essential for better control of secondary HPT and improved patient outcomes.

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...